Skip to content

Intensity of Exercise and Glucose Metabolism

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01649219
Acronym
PreDiabEx
Enrollment
80
Registered
2012-07-25
Start date
2010-01-31
Completion date
2013-06-30
Last updated
2012-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prediabetes

Keywords

Prediabetes, objectively measured exercise, glucose and lipid metabolism, dose response, muscle metabolism.

Brief summary

Our aim is to investigate the effects of a 12-week structured aerobic exercise on fasting and 2 h glucose, insulin and lipid concentrations in sedentary overweight subjects in whom impaired fasting glucose and/or impaired glucose tolerance was observed for the first time.

Detailed description

Study type: Interventional Study design: Randomized Endpoint classification: Changes in fasting and 2 h glucose, insulin and lipid concentrations Intervention model: Parallel assignment Masking: Open label Primary purpose: Prevention and dose response assessment of exercise on glucose and lipid metabolism Condition: Prediabetes Intervention: Supervised exercise - The training sessions of the intervention group are carried out indoors 3 times a week for 3 months and supervised by an exercise instructor and physician. Each session last for 60 min and include a 5-min warm-up and stretching, a 20-min walking at speeds 2-4 km/h depending of the participant's physical condition, a 5-min stretching and balance training, a 20-min walking, and a 10-min stretching and balance training. After 1.5 months the 5-min stretching and balance training between the two 20-min walkings is excluded, and the walking time become 45 min. No intervention: control group; couseling at baseline. Participants of the control group are advised to continue their usual physical and dietary habits. Experimental: 1 -supervised exercise intervention. No intervention: 2 - standard counseling at baseline.

Interventions

BEHAVIORALExercise

Sponsors

Finnish Diabetes Association
CollaboratorOTHER
Oulu University Hospital
CollaboratorOTHER
University of Oulu
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* prediabetes determined by 2 hr oGTT

Exclusion criteria

* any functional limitation or chronic disease that might have limited the physical exercise and testing * vigorous physical activity/exercise as revealed by questionnaire and physician exam

Design outcomes

Primary

MeasureTime frame
Glucose and lipid metabolism3-month intervention

Secondary

MeasureTime frame
Changes in muscle metabolism3-months intervention

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026